Orally effective inotropic compounds

Details Orally effective inotropic compounds Orally effective inotropic compounds

1984-03-08

1985-12-31

Waltz, Thomas A.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

514620, 560142, 564165, C07C10329, C07C 69017, A61K 31165, A61K 31225

Patent

active

045622060

ABSTRACT:
A method for increasing cardiac contractility in a warm-blooded animal suffering from acutely depressed cardiac contractility which comprises administering to said animal an effective amount of a compound of the formula ##STR1## wherein R is hydrogen or isobutyrate, or a pharmaceutically acceptable acid addition salt thereof.

REFERENCES:
patent: 3803230 (1974-04-01), Jack et al.
patent: 3816516 (1974-06-01), Cox et al.
patent: 3845123 (1974-10-01), Cox et al.
patent: 3987200 (1976-10-01), Tuttle et al.
patent: 4086272 (1978-04-01), Cox et al.
patent: 4218470 (1980-08-01), Casegrande et al.
patent: 4311706 (1982-01-01), Bodor et al.
patent: 4340603 (1982-07-01), Bodor et al.
patent: 4396627 (1983-08-01), Ainsworth et al.

Affiliated with

Also associated with

Rating

Orally effective inotropic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Orally effective inotropic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Orally effective inotropic compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1025041